You may be eligible to participate in a #prostatecancer study, EA8191/INDICATE, for patients with post-prostatectomy recurrence. Learn more: bit.ly/ea8191indicate #pcsm #ProstateCancerAware cc: @nehavapiwala

Truly enjoyed chatting w UroToday re this nationwide trial seeking to help us & our #ProstateCancer pts understand the clinical benefit of #PET -directed treatment intensification. Trying to put the horse back before the cart! National Cancer Institute JanssenUS Blue Earth Diagnostics

Meet some of the esteemed chairs of #APCCC24 , driving forward the conversation in advanced #prostatecancer . Connect with the forefront of oncology leadership. Visit now: apccc.org/apccc-2024/sci…
#OncologyLeaders aurelius omlin silke gillessen Derya Tilki, MD Neha Vapiwala neal shore

Excited for this collaboration with Zeke Emanuel Neha Vapiwala Mendel.ai testing a Human + NLP collaborative platform to improve the efficiency of eligibility assessment in #clinicaltrials . Penn Medicine - Abramson Cancer Center Penn Cancer Innovation

The ASCO elections are OPEN!! Please take time to help us select the next leaders for this incredible organization! And congrats to Dr. Small - we are in great hands! Conquer Cancer, the ASCO Foundation Sumanta K. Pal, MD, FASCO ASCOPres Eric Winer, MD Cardinale B. Smith Neha Vapiwala Nathan A. Pennell MD, PhD, FASCO

brnw.ch/21wE3KK

Many agree critical questions remain re: clinical value of treating #ProstateCancer seen only on PET. So let’s get some answers & prove that our treatments help #patients more than they hurt ZERO Prostate Cancer UroToday.com

Communities are key to achieving shared goals, regardless of our backgrounds & identities. It’s a privilege to be part of this one. #PCF #HealthEquity UroToday.com

ASTRO’s statement in support of patients and communities affected by the conflict in Israel:

The future of medicine & #radonc is brighter knowing these 2 superstars are in it 👏

Diligently conducted trial demonstrating #radiotherapy can be a safe & effective tx option for inoperable primary #kidneycancer . Having options matters to #cancer pts - and to all who care for them, regardless of specialty

🧵2/ SABR is a novel treatment for primary #kidneycancer which is non-invasive and has fewer technical limitations than thermal ablation. We tested SABR in a 🦘&🌷phase II trial for primary RCC that was inoperable or high-risk for surgery. The benchmark was 90% control at 1-year.

Do you have #ProstateCancer that has returned after prostatectomy? If so, you may be able to participate in this study of potential new treatment approaches. Learn more about the EA8191/INDICATE study: bit.ly/ea8191indicate #pcsm #ProstateCancer Aware cc: @nehavapiwala

Incredible multidisciplinary PCF symposium - inspired by both my GU colleagues on stage & the young talent in the audience who will ask - & answer - the tough questions we haven’t even thought of yet

It’s an escalating process - citations, site visit, warning, probation, withdrawal of accreditation. No magic number or formula - 1 serious & persistent citation may be enough. Committee deliberation & decision. Michael Steinberg MD Prajnan Das, MD, MS, MPH

Yet more game (mind?)-changing work from the UK 🙇🏽‍♀️Kudos to Prof Ananya💙 & team for advancing this discussion & Ashish M. Kamat, MD, MBBS for always engaging. The definition of multi-D professionalism.

Churchill said, “We make a living by what we get, but we make a life by what we give.” That’s mentorship, and these 3 #radonc colleagues are exemplars of how it’s done. 👏

An all-star line up of leaders who happen to be women. Congrats to #aapm2023 on this session poised to inspire another generation 👏

Huge congratulations to the one & only Sameer Keole as our incoming ASTRO Pres! And to all of the newly elected Board & Nom Cmte members! 🎊It’s an incredible experience & you all are yet more reasons to be excited for our future. We know there’s a lot to fix, and we will

Absolute pleasure to meet Yüksel Ürün IRL @ his first ASCO LDP mtg today - his enthusiasm is infectious & his energy a reminder of why oncologists make the best colleagues. Excited to see what new frontiers this latest cohort will forge

We are so excited for our new Medical Physics Residents starting today! Welcome to the UPenn RadOnc Family.
#radiation , #radiotherapy , #radiation therapy, #radiation oncology, #radonc , #radiation therapist #radiation treatment, #medphys , #cyberknife , #radiosurgery , #protontherapy